Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that management will ...

Discover key insights with the "Hypoglycemia - Global Clinical Trials Review, 2025," providing a detailed overview of the global hypoglycemia clinical trials landscape. Access top-line data on trial ...

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. To continue reading ...

Academic detailing plus pre-visit patient activation was associated with sustained diabetes deprescribing rates at 12 months in older adults with T2D.

An army doctor successfully saved the life of a 75-year-old man mid-flight by recognising and treating the signs of ...

High morning blood sugar levels can mean inadequate blood sugar control, but it can also mean a reaction to early morning ...

In their experiments, the scientists created low blood sugar conditions in mice, some of which had diabetes. They found that ...

Sidney, MT– Sidney Health Center is proud to announce it has been honored with the 2024 Yellowstone Quality Award by ...

Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) is one of the best low priced pharma stocks to buy now. On July 13, Amylyx Pharmaceuticals announced new exploratory analyses from its Phase 2 PREVENT and ...

Glucopilot dynamic dosing algorithm was associated with improved glycemic control especially among subgroups with ...

Dogs predict blood sugar changes before a glucose monitor can. They can “detect scents associated with hyperglycemia and ...